» Authors » Julianne D Jett

Julianne D Jett

Explore the profile of Julianne D Jett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 198
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jett J, Tyutyunnyk D, Beck R, Palmer K, Ryan D, Sanchez J, et al.
Contemp Clin Trials . 2025 Jan; 150:107807. PMID: 39824379
Background: Contingency management (CM) is an intervention for alcohol use disorder (AUD) that reinforces abstinence, as confirmed by alcohol biomarkers. CM is usually brief (12-16 weeks) despite evidence that longer...
2.
Keshtkar M, Tyutyunnyk D, King P, Palmer K, Brigman M, Jett J, et al.
Drug Alcohol Depend Rep . 2024 Oct; 13:100284. PMID: 39430604
Objective: The study objective was to determine factors associated with obtaining COVID-19 vaccination in people with co-occurring alcohol use disorder (AUD) and serious mental illness (SMI). Methods: Survey responses were...
3.
Jett J, Beck R, Tyutyunnyk D, Sanchez J, Weeks D, Javors M, et al.
Am J Drug Alcohol Abuse . 2024 Jan; 50(2):162-172. PMID: 38284925
Phosphatidylethanol (PEth) is a blood-based biomarker for alcohol consumption that can be self-collected and has high sensitivity, specificity, and a longer detection window compared to other alcohol biomarkers. We evaluated...
4.
Jett J, Kordas G, Parent S, Keshtkar M, Shin R, King P, et al.
J Addict Med . 2023 Jun; 17(3):305-311. PMID: 37267173
Objective: Serious mental illnesses (SMI) and alcohol use disorder (AUD) co-occurrence (SMI-AUD) is common, yet little is known about the prevalence and risk factors of cognitive impairment for this population....
5.
Jett J, Beck R, Tyutyunnyk D, Sanchez J, Lopez-Cruzan M, Ginsburg B, et al.
Alcohol Clin Exp Res (Hoboken) . 2023 Feb; 47(4):748-755. PMID: 36811188
Background: Phosphatidylethanol 16:0/18:1 (PEth), found in whole blood, is a biomarker for alcohol consumption with high sensitivity, specificity, and a long detection window. The TASSO-M20 device is used to self-collect...
6.
Jett J, Bulin S, Hatherall L, McCartney C, Morilak D
Neuroscience . 2017 Jan; 346:284-297. PMID: 28131625
Deficits in cognitive flexibility, the ability to modify behavior in response to changes in the environment, contribute to the onset and maintenance of stress-related neuropsychiatric illnesses, such as depression. Cognitive...
7.
Jett J, Boley A, Girotti M, Shah A, Lodge D, Morilak D
Psychopharmacology (Berl) . 2015 May; 232(17):3123-33. PMID: 25986748
Rationale: Acute low-dose administration of the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, produces rapid and sustained antidepressant-like effects in humans and rodents. Recently, we found that the long-lasting effect of ketamine...
8.
Heisler J, Morales J, Donegan J, Jett J, Redus L, OConnor J
J Vis Exp . 2015 Mar; (96). PMID: 25741905
Cognitive impairment, particularly involving dysfunction of circuitry within the prefrontal cortex (PFC), represents a core feature of many neuropsychiatric and neurodevelopmental disorders, including depression, post-traumatic stress disorder, schizophrenia and autism...
9.
Jett J, Morilak D
Neuropsychopharmacology . 2012 Nov; 38(4):585-95. PMID: 23132268
Cognitive impairments associated with dysfunction of the medial prefrontal cortex (mPFC) are prominent in stress-related psychiatric disorders. We have shown that enhancing noradrenergic tone acutely in the rat mPFC facilitated...
10.
Bondi C, Jett J, Morilak D
Prog Neuropsychopharmacol Biol Psychiatry . 2010 Apr; 34(6):913-23. PMID: 20417676
Chronic stress is a risk factor for many psychopathological conditions, including depression and anxiety disorders. Cognitive impairments associated with prefrontal cortical dysfunction are a major component of such illnesses. Using...